|
Market Cap (1-Jul) $176,237,888 (1,192nd) |
Close (28-Sep) $0.205 |
Volume (28-Sep) 0 |
Shortsold (21-Sep) 297,501 (0.03%) (573rd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.009 |
RAP released this announcement to the ASX on 18 August 2021, 8:54. The announcement is not marked as price sensitive, and is 30 page(s) in length and 9.06MB in size.
You can view all announcements from RAP and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAP was 0.281% short sold according to ASIC data. It was ranked the 347th most shorted stock on the ASX. It remains ranked 573rd as of the latest reported data (21 September 2022).
| Other Recent Announcements from RAP | |
|---|---|
| Removal from Official List | 27 September 2022, 11:58 |
| Scheme of Arrangement has been Implemented | 26 September 2022, 16:28 |
| Ceasing to be a substantial holder | 20 September 2022, 8:09 |
| Investor Webinar Presentation | 18 August 2021, 8:54 |
| ResApp expands COVID-19 clinical program | 9 August 2021, 8:44 |
| Alodokter to launch ResAppDx in Indonesia | 4 August 2021, 9:56 |
| Medgate enters licence agreement with ResApp Health | 4 August 2021, 9:56 |
You must be logged in to post a reply.
ResApp Health 